Your browser doesn't support javascript.
loading
Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis.
Aymerich, Claudia; Pedruzo, Borja; Pacho, Malein; Laborda, María; Herrero, Jon; Pillinger, Toby; McCutcheon, Robert A; Alonso-Alconada, Daniel; Bordenave, Marta; Martínez-Querol, Maria; Arnaiz, Ainara; Labad, Javier; Fusar-Poli, Paolo; González-Torres, Miguel Ángel; Catalan, Ana.
Afiliação
  • Aymerich C; Psychiatry Department, Basurto University Hospital, Basque Health Service (Osakidetza), Bilbao, Spain. Biocruces Bizkaia Health Research Institute, Barakaldo, Spain. Electronic address: claudia.aymerichnicolas@osakidetza.eus.
  • Pedruzo B; Psychiatry Department, Basurto University Hospital, Basque Health Service (Osakidetza), Bilbao, Spain.
  • Pacho M; Psychiatry Department, Basurto University Hospital, Basque Health Service (Osakidetza), Bilbao, Spain.
  • Laborda M; Psychiatry Department, Basurto University Hospital, Basque Health Service (Osakidetza), Bilbao, Spain.
  • Herrero J; Psychiatry Department, Basurto University Hospital, Basque Health Service (Osakidetza), Bilbao, Spain.
  • Pillinger T; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; MRC London Institute of Medical Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, London, UK.
  • McCutcheon RA; Department of Psychiatry, University of Oxford, UK. Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; Psychiatric Imaging Group, Medical Research Council, London Institute of Medical Sciences, Hammersmith Hospital, London, UK; I
  • Alonso-Alconada D; Department of Cell Biology and Histology, School of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain.
  • Bordenave M; Psychiatry Department, Basurto University Hospital, Basque Health Service (Osakidetza), Bilbao, Spain.
  • Martínez-Querol M; Psychiatry Department, Donostia University Hospital, Donostia, Spain.
  • Arnaiz A; Erandio Mental Health Center, Basque Health Service (Osakidetza), Erandio, Spain. Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
  • Labad J; Mental Health Networking Biomedical Research Centre (CIBERSAM), Spain. Salut Mental Taulí, Parc Taulí University Hospital, I3PT, Autonomous University of Barcelona, Sabadell, Barcelona, Spain.
  • Fusar-Poli P; Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK; Section of Psychiatry, Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy; OASIS s
  • González-Torres MÁ; Psychiatry Department. Biocruces Bizkaia Health Research Institute, OSI Bilbao-Basurto. School of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain; Centro de Investigación en Red de Salud Mental. (CIBERSAM), Instituto de Salud Carlos III, Plaza de Cruces 12, 48903 Barak
  • Catalan A; Psychiatry Department. Biocruces Bizkaia Health Research Institute, OSI Bilbao-Basurto. School of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain; Centro de Investigación en Red de Salud Mental. (CIBERSAM), Instituto de Salud Carlos III, Plaza de Cruces 12, 48903 Barak
Psychoneuroendocrinology ; 150: 106049, 2023 04.
Article em En | MEDLINE | ID: mdl-36758330
ABSTRACT
IMPORTANCE Alterations in prolactin and cortisol levels have been reported in antipsychotic naïve patients with first episode psychosis (FEP). However, it has been studied in very small samples, and inter-group variability has never been studied before.

OBJECTIVE:

To provide estimates of standardized mean differences (SMD) and inter-group variability for prolactin, cortisol awakening response (CAR) and morning cortisol concentrations in antipsychotic naïve FEP (AN-FEP) patients and healthy controls (HC). DATA SOURCES BIOSIS, KCI, MEDLINE, Russian Science Citation Index, SciELO, Cochrane, PsycINFO, Web of Science were searched from inception to February 28, 2022. STUDY SELECTION Peer-reviewed cohort studies that reported on prolactin or cortisol blood concentrations in AN- FEP patients and HC were included. DATA EXTRACTION AND

SYNTHESIS:

Study characteristics, means and standard deviations (SD) were extracted from each article. Inter group differences in magnitude of effect were estimated using Hedges g. Inter-group variability was estimated with the coefficient of variation ratio (CVR). In both cases estimates were pooled using random-effects meta-analysis. Differences by study-level characteristics were estimated using meta-regression. PRISMA guideline was followed (No. CRD42022303555). MAIN OUTCOMES AND

MEASURES:

Prolactin, CAR and morning cortisol blood concentrations in AN-FEP group in relation to HC group.

RESULTS:

Fourteen studies for prolactin (N = 761 for AN-FEP group, N = 687 for HC group) and twelve studies for morning cortisol (N = 434 for AN-FEP group, N = 528 for HC group) were included. No studies were found in CAR in AN-FEP patients. Mean SMD for prolactin blood concentration was 0.88 (95% CI 0.57, 1.20) for male and 0.56 (95% CI 0.26, 0.87) for female. As a group, AN-FEP presented greater inter-group variability for prolactin levels than HC (CVR=1.28, 95% CI 1.02, 1.62). SMD for morning cortisol concentrations was non-significant 0.34 (95% CI -0.01, 0.69) and no inter-group variability significant differences were detected CVR= 1.05 (95% CI 0.91, 1.20). Meta-regression analyses for age and quality were non-significant. Funnel plots did not suggest a publication bias. CONCLUSIONS AND RELEVANCE Increased prolactin levels were found in AN-FEP patients. A greater inter-group variability in the AN-FEP group suggests the existence of patient subgroups with different prolactin levels. No significant abnormalities were found in morning cortisol levels. Further research is needed to clarify whether prolactin concentrations could be used as an illness biomarker.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Antipsicóticos Tipo de estudo: Observational_studies / Prognostic_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Antipsicóticos Tipo de estudo: Observational_studies / Prognostic_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article